Search Results - "Kiyota, N"

Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02) by Tahara, M., Kiyota, N., Yokota, T., Hasegawa, Y., Muro, K., Takahashi, S., Onoe, T., Homma, A., Taguchi, J., Suzuki, M., Minato, K., Yane, K., Ueda, S., Hara, H., Saijo, K., Yamanaka, T.

“…The standard of care for first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) is combination treatment…”
Get full text

Effect of tumor burden and growth rate on treatment outcomes of nivolumab in head and neck cancer by Suzuki, C., Kiyota, N., Imamura, Y., Rikitake, J., Sai, S., Koyama, T., Hyogo, Y., Nagatani, Y., Funakoshi, Y., Toyoda, M., Otsuki, N., Nibu, KI, Minami, H.

“…Background Nivolumab improves overall survival (OS) in patients with platinum-refractory recurrent and metastatic head and neck squamous cell carcinoma (R/M…”
Get full text

Patterns of practice for bone metastases in Japan: Use of questionnaires to promote a multidisciplinary approach by Nakamura, N., Sakai, Y., Matsubara, N., Kakutani, K., Akisue, T., Kiyota, N., Minami, H.

Get full text

LBA36 Nivolumab (N) + ipilimumab (I) vs EXTREME as first-line (1L) treatment (tx) for recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Final results of CheckMate 651 by Argiris, A., Harrington, K., Tahara, M., Ferris, R.L., Gillison, M., Fayette, J., Daste, A., Koralewski, P., Mesia Nin, R., Saba, N.F., Mak, M., Álvarez Avitia, M.A., Guminski, A., Müller-Richter, U., Kiyota, N., Roberts, M., Khan, T.A., Miller-Moslin, K., Wei, L., Robert Haddad, R.

Get full text

Pan-Asian adaptation of the EHNS–ESMO–ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck by Keam, B., Machiels, J.-P., Kim, H.R., Licitra, L., Golusinski, W., Gregoire, V., Lee, Y.G., Belka, C., Guo, Y., Rajappa, S.J., Tahara, M., Azrif, M., Ang, M.K., Yang, M.-H., Wang, C.-H., Ng, Q.S., Wan Zamaniah, W.I., Kiyota, N., Babu, S., Yang, K., Curigliano, G., Peters, S., Kim, T.W., Yoshino, T., Pentheroudakis, G.

“…The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of squamous…”
Get full text

Nutritional support dependence after curative chemoradiotherapy in head and neck cancer: A supplementary analysis of a phase II trial (JCOG0706S1) by Imamura, Y., Kiyota, N., Akimoto, T., Ogawa, G., Eba, J., Minami, S., Hasegawa, Y., Iwae, S., Monden, N., Matsuura, K., Fujii, H., Onozawa, Y., Homma, A., Hayashi, R., Tahara, M.

Get full text

A randomized phase III study to evaluate the value of the omission of prophylactic neck dissection for stage I/II tongue cancer (RESPOND: JCOG1601) by Hanai, N., Asakage, T., Kiyota, N., Homma, A., Monden, N., Fukushima, H., Fujii, T., Ogawa, T., Tanaka, K., Mizusawa, J., Eba, J., Hayashi, R.

Get full text

Adjuvant treatment for post-operative head and neck squamous cell carcinoma by Kiyota, Naomi, Tahara, Makoto, Fujii, Masato

“…One of the mainstays of treatment for locally advanced head and neck squamous cell carcinoma is surgery. However, for post-operative patients with high-risk…”
Get full text

Corrigendum to 'A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody': ESMO Open volume 9 issue 6 (2024) 103476 by Koyama, T, Kiyota, N, Boku, S, Imamura, Y, Shibata, N, Satake, H, Tanaka, K, Hayashi, H, Onoe, T, Asada, Y, Yamazaki, T, Nose, T, Ohata, S, Nagatani, Y, Kimbara, S, Funakoshi, Y, Teshima, M, Shinomiya, H, Minami, H

Get full text

A phase II trial of docetaxel plus cisplatin in recurrent and/or metastatic non-squamous cell carcinoma of head and neck by Imamura, Y., Kiyota, N., Tanaka, K., Hayashi, H., Ota, I., Nario, K., Hirano, S., Arai, A., Iwae, S., Onoe, T., Minami, S., Shimada, T., Yane, K., Yamazaki, T., Nagatani, Y., Toyoda, M., Otsuki, N., Nibu, K.-I., Minami, H.

Get full text

Changes in event-related potentials associated with postural adaptation during floor oscillation by Fujiwara, K, Maeda, K, Irei, M, Mammadova, A, Kiyota, N

“…Highlights ► Negative ERP peak was observed around anterior floor’s reversal after adaptation. ► Negative ERP correlated with activity of gastrocnemius before…”
Get full text

A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody by Koyama, T., Kiyota, N., Boku, S., Imamura, Y., Shibata, N., Satake, H., Tanaka, K., Hayashi, H., Onoe, T., Asada, Y., Yamazaki, T., Nose, T., Ohata, S., Nagatani, Y., Kimbara, S., Funakoshi, Y., Teshima, M., Shinomiya, H., Minami, H.

“…An important unmet need for new treatment options remains for patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M-HNSCC)…”
Get full text

Radiation-Induced Hypothyroidism in Squamous Cell Carcinoma of the Head and Neck: A Dose-Volume Histogram Analysis by Miyawaki, D, Mukumoto, N, Ejima, Y, Yoshida, K, Ishihara, T, Kiyota, N, Saito, M, Otsuki, N, Nibu, K.I, Sasaki, R

Get full text

Corrigendum to ‘A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody’: [ESMO Open volume 9 issue 6 (2024) 103476] by Koyama, T., Kiyota, N., Boku, S., Imamura, Y., Shibata, N., Satake, H., Tanaka, K., Hayashi, H., Onoe, T., Asada, Y., Yamazaki, T., Nose, T., Ohata, S., Nagatani, Y., Kimbara, S., Funakoshi, Y., Teshima, M., Shinomiya, H., Minami, H.

Get full text

Relationship between C-reactive protein and visceral adipose tissue in healthy Japanese subjects by Saijo, Y., Kiyota, N., Kawasaki, Y., Miyazaki, Y., Kashimura, J., Fukuda, M., Kishi, R.

“…Aim:  Recent studies have suggested that the elevated C‐reactive protein (CRP) levels are associated with body fat, especially visceral adipose tissue, but…”
Get full text

2842 Radiation induced hypothyroidism in squamous cell carcinoma of the head and neck: A dose-volume histogram analysis by Miyawaki, D, Mukumoto, N, Ejima, Y, Yoshida, K, Ishihara, T, Kiyota, N, Saito, M, Otsuki, N, Nibu, K.I, Sasaki, R

Get full text

2864 Defining 131I-refractory differentiated thyroid cancer: efficacy and safety of lenvatinib by 131I-refractory criteria in the SELECT trial by Kiyota, N, Robinson, B, Shah, M, Hoff, A.O, Taylor, M, Li, D, Dutcus, C, Lee, E.K, Kim, S.B, Tahara, M

Get full text

Radiation Therapy for T3/T4 Squamous Cell Carcinoma of Hypopharynx: A Retrospective Comparison Between Definitive Radiation Therapy and Surgery Followed by Postoperative Radiation Therapy by Matsuo, Y, Yoshida, K, Miyawaki, D, Ejima, Y, Ishihara, T, Nishikawa, R, Sulaiman, N.S, Inoue, Y, Nishimura, H, Kiyota, N, Saito, M, Otsuki, N, Nibu, K, Sasaki, R

Get full text

P1-23 Effects of anti-saccade training with neck flexion on eye movement performance, presaccadic potentials and prefrontal hemodynamics in the elderly by Kiyota, N, Fujiwara, K

Get full text

Radiation-Induced Hypothyroidism in Squamous Cell Carcinoma of the Head and Neck: Comparison Between Concurrent Chemoradiation Therapy and Radiation Therapy Alone by Miyawaki, D, Yoshida, K, Ejima, Y, Nishimura, H, Sulaiman, N.S, Kiyota, N, Saito, M, Otsuki, N, Nibu, K, Sasaki, R

Get full text